Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Growth Equities was a premier boutique investment bank and institutional brokerage firm that specialized in the life sciences and technology sectors. Founded in 1991 and headquartered in San Francisco, the firm established itself as a leading underwriter and advisor for emerging biotechnology companies. It was renowned for its deep sector expertise, providing specialized equity research and investment banking services that helped capitalize the biotech industry during its formative years. The firm played a key role in numerous initial public offerings and secondary offerings, connecting innovative healthcare companies with institutional capital. In February 2009, Pacific Growth Equities was acquired by Wedbush Morgan Securities, which integrated the firm's specialized teams into its own healthcare and technology platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Growth.